| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614724 | Journal of Cardiology | 2017 | 9 Pages |
Abstract
Ablation under dabigatran therapy is an expensive therapeutic option, but it might benefit patients with a low quality of life and a high CHADS2 score.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Takehiro MD, PhD, FHRS, Ataru PhD, Shunya MD, PhD, Kazuaki MD, Shin MD, Akira MD, Yoshinori MD, PhD, Takahiko MD, PhD, Nobuhiro MD, PhD, Kotaro MD, PhD, FHRS, Yoko MD, PhD, Yoshiyasu MD, PhD, FHRS, Keiichi MD, PhD, Seiji MD, PhD,